Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 15,450
-250 (-1.59%)
At close: Dec 5, 2025
KRX:271980 Revenue
Jeil Pharmaceutical Co.,Ltd had revenue of 134.76B KRW in the quarter ending September 30, 2025, a decrease of -22.72%. This brings the company's revenue in the last twelve months to 621.98B, down -10.85% year-over-year. In the year 2024, Jeil Pharmaceutical Co.,Ltd had annual revenue of 704.54B, down -3.01%.
Revenue (ttm)
621.98B
Revenue Growth
-10.85%
P/S Ratio
0.36
Revenue / Employee
656.79M
Employees
947
Market Cap
225.13B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |